Zecca, Chiara Disanto, Giulio Sacco, Rosaria Riccitelli, Gianna Gobbi, Claudio Additional file 1: of Use of glatiramer acetate between 2010–2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients Comparison between the baseline characteristics of patients monitored (V1 V2) and those who had no data on V2 (noV1 V2). (DOCX 15 kb) CIS;GA;Glatiramer acetate;Multiple sclerosis;Relapsing remitting;Therapy 2019-07-12
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Use_of_glatiramer_acetate_between_2010_2015_effectiveness_safety_and_reasons_to_start_GA_as_first_or_second_line_treatment_in_Swiss_multiple_sclerosis_patients/8867006
10.6084/m9.figshare.8867006.v1